Single-cell longitudinal analysis of regeneration in human pancreatic slices

人胰腺切片再生的单细胞纵向分析

基本信息

项目摘要

PROJECT SUMMARY We have described a subpopulation of human pancreatic ductal cells with progenitor-like characteristics. These cells can be sorted using antibodies against the BMP receptor 1A (ALK3bright+) and P2RY1, a surrogate surface marker for PDX1 identified by our team. ALK3bright+/P2RY1+ cells proliferate when exposed to BMP-7, and differentiate into all adult pancreatic cell types, including functional β-cells, upon BMP-7 withdrawal. scRNAseq of the ALK3bright+ fraction of human pancreatic donors confirmed the existence of clusters with progenitor-like features, with substantial evidence suggesting that such features may be acquired by de- differentiation. When transplanted into immune-deficient mice, sorted cell populations enriched in markers differentially expressed in these clusters self-organize into ‘micro-pancreata’ with native-like cytoarchitecture and functional endocrine cells. More recently, we have developed the means to study the dynamic processes of progenitor cell-dependent regeneration using human pancreatic slices (HPSs). We have achieved functional long-term (>10d) culture of HPSs, which allows for the longitudinal tracking of β-cell regeneration in a setting that is widely considered the closest approximation in vitro to a native pancreas. BMP signaling-dependent regeneration was established in slices from healthy and, more importantly, T1D and T2D donors. Numerous single-cell analyses of the pancreas, included our own, support the emerging view that specific lineages are in a state of flux between differentiation stages. However, all these analyses only offer a snapshot of the tissue at any given time point. Conclusions about potential developmental/regeneration paths are exclusively based on bioinformatics inferences. We hypothesize that the combination of long-term organotypic culture with lineage-tracing in vitro and sequential single-cell analyses will allow us, for the first time, to dynamically map cell fate changes –e.g., by conducting longitudinal scRNAseq of slices from the same donor across multiple time points after BMP-7 addition. Furthermore, we contend that this system will enable the real- time visualization and in-depth, single-cell resolution study of potential de-differentiation events, should they happen in response to different sources of stress in human slices. These approaches offer a wealth of new research possibilities that were downright unfeasible prior to the development of these methods. Our research design is expected to help us realize the full potential of single-cell transcriptomics to unveil dynamic biological processes, model human pancreatic disease, and, ultimately, enable the development of novel therapeutic approaches to induce regeneration. We will test the above hypotheses by pursuing the following specific aims: (1) Longitudinal scRNAseq of same-donor T1D/T2D HPSs following stimulation of the BMP pathway. (2) Study of the effect of stress, inflammation and de-differentiation on BMP-7-mediated induction of β-cell formation in HPSs; (3) Functional characterization of neogenic β-cells through “slice-on-a-chip” approaches; and (4) Determination of in vivo regeneration potential of progenitor cells sorted from healthy and T1D/T2D donors using a xenotransplantation model.
项目摘要 我们已经描述了具有祖细胞样特征的人类胰腺导管细胞的亚群。 可以使用针对BMP受体1a(ALK3BRIGHT+)和P2RY1的抗体对这些细胞进行分类 PDX1的表面标记是由我们的团队促进的。 并在BMP-7退出后分为所有成年胰腺细胞类型,包括功能性β细胞。 Alk3bright+人类胰腺供体的scrnaseq证实存在群集 祖细胞样特征,并有大量证据表明,这种特征可以通过DE-获得 分化时。 在这些群集中差异表达的自我组织形成“与天然的leaata”,具有本地类细胞结构和 功能性内分泌细胞。 祖细胞依赖性的使用人类胰腺切片(HPSS)。 HPSS的长期(> 10d)培养 这被广泛认为是与天然胰腺最接近的近似值。 在健康,更重要的是T1D和T2D供体的缝隙中建立了再生。 palcress的大量单细胞分析包括我们自己的,支持新兴观点 谱系处于分化阶段之间的通量。 在任何给定时间点的组织。 基于生物信息学推断,我们假设长期器官的结合 在体外和顺序单细胞分析中进行谱系追踪的培养将使我们首次进入。 动态的地图细胞命运变化 - 例如 在添加BMP-7之后的多个时间点。 时间可视化和深入的,单细胞的潜在脱不同事件的分辨率, 发生在人类切片中的不同压力来源的情况下发生。 在开发这些方法之前,研究可能性是彻头彻尾的 设计有望帮助我们实现单细胞转录组学揭示Dynabeil动态生物学的全部潜力 过程,建模人类胰腺疾病,并最终使新的治疗疗法的发展 诱导再生的方法。 (1)刺激BMP途径后,相同T1D/T2D HPS的纵向SCRNASEQ。 压力,炎症和脱节性对BMP-7介导的β细胞形成诱导的影响 HPSS;(3)通过“片段切片”方法对新生β细胞的功能表征; 使用健康和T2D供体排序的祖细胞的体内再生潜力的确定 异种解雇模型。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Juan Dominguez-Bendala其他文献

Juan Dominguez-Bendala的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Juan Dominguez-Bendala', 18)}}的其他基金

Single-cell longitudinal analysis of regeneration in human pancreatic slices
人胰腺切片再生的单细胞纵向分析
  • 批准号:
    10336196
  • 财政年份:
    2021
  • 资助金额:
    $ 38.38万
  • 项目类别:
Single-cell longitudinal analysis of regeneration in human pancreatic slices
人胰腺切片再生的单细胞纵向分析
  • 批准号:
    10677724
  • 财政年份:
    2021
  • 资助金额:
    $ 38.38万
  • 项目类别:
HIGH-RESOLUTION CHARACTERIZATION OF HUMAN DUCTAL PROGENITOR CELLS AND THEIR REGENERATION POTENTIAL
人类导管祖细胞及其再生潜力的高分辨率表征
  • 批准号:
    10252070
  • 财政年份:
    2018
  • 资助金额:
    $ 38.38万
  • 项目类别:
HIGH-RESOLUTION CHARACTERIZATION OF HUMAN DUCTAL PROGENITOR CELLS AND THEIR REGENERATION POTENTIAL
人类导管祖细胞及其再生潜力的高分辨率表征
  • 批准号:
    9788440
  • 财政年份:
    2018
  • 资助金额:
    $ 38.38万
  • 项目类别:
HIGH-RESOLUTION CHARACTERIZATION OF HUMAN DUCTAL PROGENITOR CELLS AND THEIR REGENERATION POTENTIAL
人类导管祖细胞及其再生潜力的高分辨率表征
  • 批准号:
    10186697
  • 财政年份:
    2018
  • 资助金额:
    $ 38.38万
  • 项目类别:
Preclinical characterization of THR-123 to induce pancreatic beta cell regeneration (Phase I)
THR-123 诱导胰腺 β 细胞再生的临床前表征(第一阶段)
  • 批准号:
    9465072
  • 财政年份:
    2017
  • 资助金额:
    $ 38.38万
  • 项目类别:
technologyIn vitro maturation of BMP-7-responsive pancraeatic beta cell progenitors by oxygen modulation
技术通过氧调节使 BMP-7 反应性胰腺 β 细胞祖细胞体外成熟
  • 批准号:
    9344589
  • 财政年份:
    2015
  • 资助金额:
    $ 38.38万
  • 项目类别:
A perfluorocarbon-based culture device for beta cell biology applications (Phase
用于 β 细胞生物学应用的基于全氟化碳的培养装置(Phase
  • 批准号:
    8487397
  • 财政年份:
    2009
  • 资助金额:
    $ 38.38万
  • 项目类别:
A perfluorocarbon-based culture device for beta cell biology applications (Phase
用于 β 细胞生物学应用的基于全氟化碳的培养装置(Phase
  • 批准号:
    8314435
  • 财政年份:
    2009
  • 资助金额:
    $ 38.38万
  • 项目类别:
Somatic cell reprogramming by protein transduction
通过蛋白质转导进行体细胞重编程
  • 批准号:
    7761208
  • 财政年份:
    2009
  • 资助金额:
    $ 38.38万
  • 项目类别:

相似国自然基金

新细胞因子FAM19A4联合CTLA-4抗体在肿瘤治疗的功能和机制研究
  • 批准号:
    32370967
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
基于吡啶盐的可裂解抗体-药物偶联方法研究
  • 批准号:
    22307081
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
人和小鼠中新冠病毒RBD的免疫原性表位及其互作抗体的表征和结构组学规律的比较研究
  • 批准号:
    32371262
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
基于淬灭抗体的重金属镉快速定量免疫分析
  • 批准号:
    22306074
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
TFAM条件性敲除重塑树突状细胞免疫代谢增强PD-1抗体抗肿瘤作用的机制研究
  • 批准号:
    82303723
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

The role of BET proteins in pathological cardiac remodeling
BET蛋白在病理性心脏重塑中的作用
  • 批准号:
    10538142
  • 财政年份:
    2023
  • 资助金额:
    $ 38.38万
  • 项目类别:
Bioinformatics Core
生物信息学核心
  • 批准号:
    10404414
  • 财政年份:
    2023
  • 资助金额:
    $ 38.38万
  • 项目类别:
Role of neonatal lung macrophages in mediating resilience to hyperoxia induced lung injury via TREM2 signaling
新生儿肺巨噬细胞通过 TREM2 信号传导介导高氧诱导肺损伤的恢复能力
  • 批准号:
    10720557
  • 财政年份:
    2023
  • 资助金额:
    $ 38.38万
  • 项目类别:
Targeting TGFb In Osteogenesis Imperfecta
靶向 TGFb 治疗成骨不全症
  • 批准号:
    10736736
  • 财政年份:
    2023
  • 资助金额:
    $ 38.38万
  • 项目类别:
Intraoperative dual-labeled molecular tracer to improve surgery on neuroblastoma
术中双标记分子示踪剂改善神经母细胞瘤手术
  • 批准号:
    10737309
  • 财政年份:
    2023
  • 资助金额:
    $ 38.38万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了